home · filing · 0001663577-23-000495
8-K
filed October 12, 2023, 7:59 PM ET
ticker MDNC
CIK 0001931055
leadership
confidence high
sentiment neutral
materiality 0.40
Medinotec appoints Athanasios Spirakis to Board and Audit Committee
Medinotec Inc.
Appointed effective October 11, 2023; Spirakis will serve as independent director and audit committee member.
Spirakis, age 62, brings 34 years experience in biomedical engineering, medical devices, and healthcare technology.
Background includes roles at University of Cape Town, Groote Schuur Hospital, Macmed Orthopaedics, and Elite Surgical.
No arrangements or transactions requiring disclosure under Item 404(a) were identified.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Athanasios Spirakis
Director
Effective 2023-10-11
Filed October 12, 2023, 7:59 PM ET
Effective October 11, 2023, we have appointed Mr. Athanasios Spirakis as a member of our Board of Directors.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Athanasios Spirakis was appointed as Director at Medinotec Inc..
Action appointed
Role Director
Exact text from the filing
Effective October 11, 2023, we have appointed Mr. Athanasios Spirakis as a member of our Board of Directors.
View on SEC.gov
Source: SEC EDGAR
accession 0001663577-23-000495
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.